SEPTInvestingStart Free

ANAB 10-Q: SEC filing

AnaptysBio

Filed with the SEC on · accession 0001193125-26-458494

ANAB filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -2.1% by the first close after the filing.

Summary of the filing

AnaptysBio filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial results, royalty monetization agreements, and collaboration revenue from GSK related to Jemperli (dostarlimab).

For details, click here →How to read a 10-Q →

Key details

FilerAnaptysBio, Inc.
Collaboration partnerGlaxoSmithKline
Royalty monetization partnerSagard Healthcare Royalty Partners LP
Royalty monetization partnerDRI Healthcare Trust
LicenseeVanda Pharmaceuticals Inc.

How ANAB stock reacted

Close before

$48.77

Nov 11, 2026

First close after

-2.05%

$47.77

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ANAB, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ANAB?

Click here

Frequently asked questions

What did ANAB file with the SEC on Nov 12, 2026?

ANAB filed a 10-Q (SEC filing). AnaptysBio filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial results, royalty monetization agreements, and collaboration revenue from GSK related to Jemperli (dostarlimab).

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did ANAB stock react to this filing?

ANAB closed at $48.77 before the filing and $47.77 on Nov 12, 2026 (-2.05%).

Other ANAB SEC filings

Get alerts when ANAB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
ANAB overviewANAB analysisANAB newsLatest SEC filings